JPRN-jRCT2080223189已完成2 期
Phase2 Study of TS-141 in Child Patients With ADHD (Double-blind, Parallel Group Study)
Taisho Pharmaceutical co., LTD0 个研究点目标入组 200 人开始时间: 2016年5月9日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 6age old 至 <= 17age old（—）
- 性别
- All
入选标准
- •Child patients diagnosed with ADHD
- •- Outpatients
排除标准
- •- Having other central nervous system disease
研究者
相似试验
已完成
2 期
Phase II Study of SDT-001 in Pediatric Patients with Attention-deficit/Hyperactivity DisorderInattention symptom in patients with ADHDJPRN-jRCT1080225158SHIONOGI & CO., LTD.262
招募中
1 期
tDCS with EEG testing for ADHD in childhoodADHDF90.0Disturbance of activity and attentionDRKS00034034niversitätsklinikum Rostock20
进行中（未招募）
不适用
AZD2171 in Treating Young Patients With Previousley untreatable Primary CNS TumoursRecurrent, Progressive, or Refactory Primary CNS TumoursEUCTR2012-001154-26-Outside-EU/EEAPediatric Brain Tumour Consortium55
进行中（未招募）
3 期
Phase 3 Study of SDT-001 in Pediatric Patients with Attention-deficit/Hyperactivity DisorderJPRN-jRCT2042220012agata - Tsutae150
已完成
2 期
Classroom Study to Assess Efficacy and Safety of MTS in Pediatric Patients Aged 6-12 With ADHDAttention Deficit Disorder With HyperactivityNCT00466791Noven Therapeutics93